Paroxysmal Nocturnal Hemoglobinuria

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-10-20
Clinical Trial Update: Compassionate Use of Pozelimab and Cemdisiran Combination Therapy in Patients With Paroxysmal Nocturnal Hemoglobinuria
The clinical trial update indicates that compassionate-use access to the pozelimab and cemdisiran combination therapy for Paroxysmal nocturn…